The George Shultz Innovation Fund has awarded $250,000 to StaC12, $200,000 to Theta Neurotech, and $150,000 to CavilinQ to support the continued development and commercialization of their technologies.
Managed by the Polsky Center for Entrepreneurship and Innovation, the George Shultz Innovation Fund provides up to $250,000 in funding for early-stage tech ventures emerging from the University of Chicago, Argonne National Laboratory, Fermilab, and the Marine Biological Laboratory.
“Since moving to a single funding cycle per year, we received one of the highest numbers of applications ever for the George Shultz Innovation Fund,” said Shyama Majumdar, director of Science Accelerators and Investments at the Polsky Center. “The quality of submissions was exceptional, making it a challenge to select just four finalists. This year’s three awardees span material science, quantum computing, and medical devices — demonstrating the breadth and excellence of research emerging from the University of Chicago. As venture capital becomes increasingly difficult to secure, early-stage risk capital like the Innovation Fund plays a critical role in advancing university spinouts. Congratulations to our awardees—I’m excited to see the remarkable heights they will undoubtedly reach.”
Full story, including detail on funded projects: https://polsky.uchicago.edu/2025/06/17/three-uchicago-startups-receive-investment-from-the-george-shultz-innovation-fund/
